Vir Biotechnology, Inc. (VIR) intrinsic value & 10-year financials
Vir Biotechnology, Inc. (VIR) has a Graham intrinsic value of $127.22 per share. At $9.96 on Oct 17, 2026, the stock trades 92% below that value. Over the last 10 fiscal years revenue grew 49.8% a year to $68.6M, with an average return on invested capital of 8.4%.
- Graham intrinsic value
- $127.22
- Share price (Oct 17, 2026)
- $9.96
- Price vs Graham value
- 92% below
- Market cap
- $1.4B
- Revenue (FY2025)
- $68.6M
- Revenue growth (10-yr CAGR)
- 49.8%
- ROIC (10-yr avg)
- 8.4%
- Free cash flow (FY2025)
- -$396.6M
VIR 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $68.6M | -$438.0M | -$3.16 | -$396.6M | -699.2% | -58.5% |
| FY2024 | $74.2M | -$522.0M | -$3.83 | -$453.7M | -791.3% | -47.3% |
| FY2023 | $86.2M | -$615.1M | -$4.59 | -$800.4M | -794.0% | -47.6% |
| FY2022 | $1.6B | $515.8M | $3.83 | $1.6B | 51.6% | 44.3% |
| FY2021 | $1.1B | $528.6M | $3.96 | -$69.4M | 38.4% | 51.7% |
| FY2020 | $76.4M | -$298.7M | -$2.51 | -$197.5M | -388.9% | -89.6% |
| FY2019 | $8.1M | -$174.7M | -$1.44 | -$138.6M | -2199.7% | -56.4% |
| FY2018 | $10.7M | -$115.9M | — | -$102.3M | -1112.6% | 95.3% |
| FY2017 | $2.7M | -$69.9M | — | -$69.1M | -3009.5% | 183.3% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Vir Biotechnology, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Vir Biotechnology, Inc. has historically struggled to out-earn its cost of capital, averaging just -11.8% ROIC.
Vir Biotechnology, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Vir Biotechnology, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $127.22 per share.